Antigen binding constructs to CD3
First Claim
Patent Images
1. A nucleic acid comprising a nucleotide sequence encoding a polypeptide comprising:
- a variable light (VL) domain comprising an amino acid sequence of SEQ ID NO;
3;
a variable heavy (VH) domain comprising an amino acid sequence of SEQ ID NO;
6 or 86;
a linker comprising an amino acid sequence of SEQ ID NO;
98, wherein the linker links the VL and the VH domains;
a CH3; and
a hinge region linking the VH domain to the CH3.
2 Assignments
0 Petitions
Accused Products
Abstract
Antigen binding constructs that bind to CD3, for example antibodies, including antibody fragments (such as minibodies and cys-diabodies) that bind to CD3, are described herein. Methods of use are described herein.
10 Citations
10 Claims
-
1. A nucleic acid comprising a nucleotide sequence encoding a polypeptide comprising:
-
a variable light (VL) domain comprising an amino acid sequence of SEQ ID NO;
3;a variable heavy (VH) domain comprising an amino acid sequence of SEQ ID NO;
6 or 86;a linker comprising an amino acid sequence of SEQ ID NO;
98, wherein the linker links the VL and the VH domains;a CH3; and a hinge region linking the VH domain to the CH3.
-
-
2. A nucleic acid comprising a nucleotide sequence encoding a humanized antigen binding construct, wherein the humanized antigen binding construct comprises:
-
a HCDR1 of the HCDR1 in SEQ ID NO;
6 or 86;a HCDR2 of the HCDR2 in SEQ ID NO;
6 or 86;a HCDR3 of the HCDR3 in SEQ ID NO;
6 or 86;a LCDR1 of the LCDR1 in SEQ ID NO;
3;a LCDR2 of the LCDR2 in SEQ ID NO;
3; anda LCDR3 of the LCDR3 in SEQ ID NO;
3,wherein the humanized antigen binding construct binds specifically to CD3, wherein the humanized antigen binding construct comprises a humanized minibody or a humanized cys-diabody, and wherein the human antigen binding construct further comprises at least one of; a LFR3 of the LFR3 in SEQ ID NO;
3;
ora HFR3 of the HFR3 in SEQ ID NO;
6 or 86. - View Dependent Claims (3, 4, 5, 6, 7, 8)
-
-
9. A nucleic acid comprising a nucleotide sequence encoding a humanized OKT3 minibody that binds to CD3, the humanized minibody comprising a polypeptide that comprises:
-
a single-chain variable fragment (scFv) that binds to CD3, the scFv comprising a variable heavy (VH) domain linked to a variable light (VL) domain, wherein the scFv comprises a LFR3 of the LFR3 in SEQ ID NO;
3, or a HFR3 of the HFR3 in SEQ ID NO;
6 or 86, or both;a hinge; a human IgG CH3 sequence; a HCDR1 of the HCDR1 in SEQ ID NO;
6 or 86;a HCDR2 of the HCDR2 in SEQ ID NO;
6 or 86;a HCDR3 of the HCDR3 in SEQ ID NO;
6 or 86;a LCDR1 of the LCDR1 in SEQ ID NO;
3;a LCDR2 of the LCDR2 in SEQ ID NO;
3; anda LCDR3 of the LCDR3 in SEQ ID NO;
3.
-
-
10. A nucleic acid comprising a nucleotide sequence encoding a humanized minibody that binds to CD3, wherein the humanized minibody comprises:
a polypeptide that comprises; a single-chain variable fragment (scFv) that binds to CD3, the scFv comprising a variable heavy (VH) domain linked to a variable light (VL) domain, wherein the scFv comprises a LFR3 of the LFR3 in SEQ ID NO;
3, or a HFR3 of the HFR3 in SEQ ID NO;
6 or 86, or both;a hinge; a human IgG CH3 sequence; a HCDR1 of the HCDR1 in SEQ ID NO;
6 or 86;a HCDR2 of the HCDR2 in SEQ ID NO;
6 or 86;a HCDR3 of the HCDR3 in SEQ ID NO;
6 or 86;a LCDR1 of the LCDR1 in SEQ ID NO;
3;a LCDR2 of the LCDR2 in SEQ ID NO;
3; anda LCDR3 of the LCDR3 in SEQ ID NO;
3.
Specification